CompletedNot Applicable

Prophylactic Peripheral Iridectomy Prevents Aphakic Angle-closure Glaucoma

China87 participantsStarted 2018-08-02

Plain-language summary

This is a retrospective, nonrandomized comparative trial with historical control to investigate the safety and efficacy of a novel progressive grasping peripheral iridectomy (PGPI) surgical method in preventing aphakic angle-closure glaucoma (AACG) following congenital cataract surgery.

Who can participate

Age range2 Months – 24 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. patients less than 2 years old;
✓. patients performed with congenital cataract surgery with or without PPI;
✓. patients with routine follow-up at ZOC.

Exclusion criteria

✕. patients with IOP ≥21 mm Hg or with congenital glaucoma or with a family history of glaucoma;
✕. patients with keratopathy, retinopathy, ocular trauma, radiation therapy or intraocular surgery;
✕. patients associated with other congenital ocular anomalies, such as anterior segment dysgenesis, microcornea/microphthalmia, persistent fetal vasculature, lens dislocation and iridocoloboma;
✕. patients with systemic diseases, such as Down's syndrome, Lowe syndrome, Stickler syndrome, maternal rubella syndrome or trisomy 13.

What they're measuring

The rate of aphakic angle-closure glaucoma

Timeframe: 18-49 months

Trial details

NCT IDNCT03610295

SponsorZhongshan Ophthalmic Center, Sun Yat-sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03-05

View on ClinicalTrials.gov More Congenital Cataract trials